Compounds for treating muscular dystrophy

Details for Australian Patent Application No. 2009238270 (hide)

Owner Summit Corporation PLC

Inventors Wynne, Graham Michael; Price, Paul Damien; Lecci, Cristina; Johnson, Peter David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009238270

Priority GB0809314.8 22.05.08 GB

Filing date 22 May 2009

Wipo publication date 10 December 2009

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

10 December 2009 Application Open to Public Inspection

  Published as AU-A-2009238270

10 December 2009 PCT application entered the National Phase

11 March 2010 Assignment before Grant

  Summit Corporation PLC The application has been assigned to Biomarin IGA Limited Assignments before Grant, Section 113

22 April 2010 Corrigenda

  Assignments Before Grant, Section 113 - 2009 Under the name Biomarin IGA Limited, Application No. 2009238270, under INID(71), correct the applicant name to BioMarin IGA Limited

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009238271-Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine metformin

2009238269-Infant swing seat